Willow Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: needle-free compounded semaglutide or tirzepatide tablets
Willow scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Willow’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Willow is an online weight-loss program from Willow Health Services (Houston) that prescribes compounded semaglutide and tirzepatide as weekly injections or daily under-the-tongue tablets. Plans start at $299/mo for semaglutide and $399/mo for tirzepatide and include the medication, your doctor evaluation, unlimited doctor messaging and free shipping. Willow currently serves 37 states.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
What is Willow?
Willow is a doctor-led telehealth program that connects adults with licensed U.S. physicians who can prescribe compounded semaglutide or tirzepatide, either as a weekly injection or as a daily tablet that dissolves under the tongue. Plans renew monthly and bundle your evaluation, physician access, round-the-clock care team support, and free shipping. It suits people who want a needle-free option or the same doctor over time, and who don't plan to use insurance.
Vetted alternatives to Willow
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Willow at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $299/mo (starting dose)
- What's included
- Medication · Consult · Shipping
- Availability
- 37 states
- FDA status
- No FDA warning letter on record
How we scored Willow
Each dimension is scored algorithmically from Willow’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
5.6/10At $299/mo (starting dose), Willow runs about 67% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.3/10Willow offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.5/10Online intake and platform experience (consult included in the price); 6 platform features disclosed.
Trust & Safety15%
8.2/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.8/10Willow is available in 37 states. FSA/HSA cards are accepted.
Support10%
6.0/10Willow provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Willow review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in 37 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $299–$399/mo across 4 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Willow
We walked Willow’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Click 'Am I eligible?' or 'Start now' on the homepage or a product page, which show the $299/mo and $399/mo starting prices.
- 2The first screen ('Personal information 01/05') asks you to select your state and tick a box agreeing to the Terms, Privacy Policy and Telehealth Consent.
- 3Per the site, a US-licensed physician reviews your assessment, usually within 24 hours, and confirms a prescription if appropriate; medication ships from a partner pharmacy.
- Starting prices for all four products are shown publicly before the assessment.
- You must agree to the Terms and Telehealth Consent on the very first screen.
- A government-issued photo ID is required before a prescription, per the FAQ.
- Plans auto-renew monthly; cancel by messaging the care team at least 2 business days before the next charge.
- The contact page's medication list hasn't been updated for tirzepatide tablets, which are sold on the homepage.
- Support through chat, the help center and email.
Willow customer support
- help@startwillow.com
GLP-1 medications Willow offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'$299/mo' on the product page; plan includes medication, evaluation, doctor access and shipping
'$299/mo' on the semaglutide tablets page
'$399/mo' on the product page
'$399/mo' on the tirzepatide tablets page
Ready to get started?
Plans and promotions change often, so check Willow's current pricing and active discounts before you decide.
What we like
- All-in plan price covers the medication, doctor evaluation, unlimited doctor messaging and shipping
- Needle-free daily tablets for both semaglutide and tirzepatide
- Names its partner compounding pharmacies in its Terms
- Publishes the list of states it serves
- Free 2-day shipping and 24/7 care team support
- Full refund if you cancel before your prescription goes to the pharmacy
Watch-outs
- Pricier than many compounded programs: $299/mo for semaglutide and $399/mo for tirzepatide
- Plans auto-renew, and you must cancel at least 2 business days before the next processing date
- Only available in 37 states
- Only starting prices are published; costs at higher doses aren't shown
- Prescription medication can't be returned once dispensed
Is Willow worth it? The short verdict
Willow is a straightforward telehealth program built around one promise: get a compounded GLP-1 in your hands quickly, evaluated and prescribed by US-licensed doctors, with the medication, the visit, and shipping all rolled into a single monthly price. At $299 a month (starting dose) for compounded semaglutide, it lands above the category median of $179 but well under what brand-name pens cost out of pocket. What sets it apart is format: Willow sells both semaglutide and tirzepatide as under-the-tongue tablets as well as injections. If you want a clean, needle-optional entry point into GLP-1 treatment and live in one of the 36 states it serves, Willow does the core job. For bundled lab work, MyStart Health covers any needed blood work in its program price and locks that price as your dose rises.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
How Willow's pricing works
Willow uses a flat, all-in subscription rather than charging a separate consult fee on top of the drug. Plans start at $299 per month (starting dose) for compounded semaglutide, as an injection or a tablet, and at $399 per month for compounded tirzepatide in either format, and Willow doesn't run a discounted first-month promo. Two pieces of fine print matter: only starting prices are published, and Willow's Terms say your subscription fee may go up or down if your prescription changes, such as with a dose increase. The exact fee and billing interval are disclosed at checkout. What you get for the charge is bundled:
- Your personalized GLP-1 medication
- Your medical evaluation and a personalized treatment plan
- Unlimited access to your Willow doctor
- 24/7 online support from the Willow Care Team
- Free and discreet shipping
That bundling matters, because some cheaper-looking programs quote a low drug price and then add visit fees or shipping. Willow's starting number covers the care and delivery too, which makes it easy to compare against the median and against the list price of brand pens without insurance.
The medications, and the format choice that sets it apart
Willow differs on format: most compounding telehealth shops offer injections only. Willow offers four options: compounded semaglutide as a weekly injection or a daily sublingual tablet, and compounded tirzepatide as a weekly injection or a daily sublingual tablet. The tablets dissolve under your tongue and are aimed squarely at people who are needle-averse and have been putting off GLP-1 treatment for that reason. If the syringe is the only thing stopping you, Willow gives you a needle-free alternative for either molecule.
Be clear-eyed about what 'compounded' means, though. These are not the FDA-approved brand products (Wegovy, Ozempic, Zepbound, Mounjaro); they're compounded versions made by compounding pharmacies. Willow's Terms name six partner pharmacies: Red Rock Home Pharmacy and Red Rock Pharmacy in Utah, Epiq Pharmacy and Empower Pharmacy in Texas, and Absolute Pharmacy and The Pharmacy Hub in Florida. Compounded medication can be a legitimate, lower-cost route, but it doesn't carry the same regulatory review as a branded pen, and Willow does not offer a brand-name option.
Who should choose Willow, and who should skip it
Choose Willow if you want a simple, single-price program, if you specifically want a no-needle tablet, or if you want both semaglutide and tirzepatide available from the same provider so you can switch molecules without changing services.
Skip Willow, or at least ask questions first, if you need brand-name medication, if you rely on insurance billing (this is a cash-pay compounded model), or if you're shopping strictly on price, since many compounded programs cost less. Check your state, too: Willow publishes its list, and it currently serves 36 states. Prime Health says it serves every state except Louisiana, with labs and unlimited clinician access in a flat monthly price. You'll also need a government-issued photo ID before a prescription is written.
Trust, safety, and cancellation
On the reassuring side, Willow prescribes through US-licensed doctors and gives you unlimited access to that doctor as part of the plan, which is the kind of ongoing oversight you want on a GLP-1. Willow has no FDA warning letters against it. The company behind it, Willow Health Services, Inc. in Houston, names its partner pharmacies and publishes its state list, which is more disclosure than many rivals offer.
Know the cancellation rules before you start: plans renew automatically. You can cancel anytime by messaging the Patient Care Team, but you need to do it at least 2 business days before your next processing date to avoid the next charge. If you cancel before your prescription is sent to the pharmacy, you get a full refund; after that, charges are non-refundable and prescription products can't be returned. You can see how we weigh disclosure and oversight in our scoring methodology.
Bottom line
Willow is a solid mainstream choice for compounded GLP-1 access starting at $299 a month (starting dose), and its tablet and injection options for both semaglutide and tirzepatide give it a reason to exist beyond price. The trade-offs are a higher-than-median starting price, dose-based price changes you only see at checkout, and coverage limited to 36 states. Needle-averse patients especially should consider it.
The Bottom Line
Willow scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Willow?
From $299/mo (starting dose). See current pricing and start your free consultation.
Willow might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Willow vs…
Willow scores7.2/10
Side-by-side pricing, medications and scores. Pick a matchup.
Willow vs Amazon One Medical
Amazon One Medical scores 8.5/10

Willow vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Willow review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Willow's current pricing
Plans from $299/mo (starting dose). Start your free consultation to check eligibility and today's price.